Jeonjinbio (A110020) Stock Overview
Develops and produces natural bio-pesticides, alternative chemical products, and other biotechnology products. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
A110020 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Jeonjinbio Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩2,885.00 |
| 52 Week High | ₩4,480.00 |
| 52 Week Low | ₩2,140.00 |
| Beta | -0.67 |
| 1 Month Change | 4.91% |
| 3 Month Change | -15.15% |
| 1 Year Change | 13.81% |
| 3 Year Change | -21.39% |
| 5 Year Change | -79.39% |
| Change since IPO | -77.37% |
Recent News & Updates
The Price Is Right For Jeonjinbio Co., Ltd. (KOSDAQ:110020) Even After Diving 28%
Sep 03
Returns On Capital Are Showing Encouraging Signs At Jeonjinbio (KOSDAQ:110020)
Jul 24Recent updates
The Price Is Right For Jeonjinbio Co., Ltd. (KOSDAQ:110020) Even After Diving 28%
Sep 03Returns On Capital Are Showing Encouraging Signs At Jeonjinbio (KOSDAQ:110020)
Jul 24We Think Jeonjinbio's (KOSDAQ:110020) Robust Earnings Are Conservative
Mar 14Jeonjinbio Co., Ltd.'s (KOSDAQ:110020) Price In Tune With Revenues
Jan 07There's Been No Shortage Of Growth Recently For Jeonjinbio's (KOSDAQ:110020) Returns On Capital
Oct 25With A 38% Price Drop For Jeonjinbio Co., Ltd. (KOSDAQ:110020) You'll Still Get What You Pay For
Jun 07Shareholders Should Be Pleased With Jeonjinbio Co., Ltd.'s (KOSDAQ:110020) Price
Apr 03Is Jeonjinbio (KOSDAQ:110020) Using Debt Sensibly?
Apr 13If You Had Bought Jeonjinbio (KOSDAQ:110020) Shares A Year Ago You'd Have Earned 101% Returns
Feb 19
Shareholder Returns
| A110020 | KR Chemicals | KR Market | |
|---|---|---|---|
| 7D | -2.4% | -2.6% | -3.3% |
| 1Y | 13.8% | 25.6% | 56.1% |
Return vs Industry: A110020 underperformed the KR Chemicals industry which returned 30.6% over the past year.
Return vs Market: A110020 underperformed the KR Market which returned 61.5% over the past year.
Price Volatility
| A110020 volatility | |
|---|---|
| A110020 Average Weekly Movement | 7.9% |
| Chemicals Industry Average Movement | 4.8% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 10.8% |
| 10% least volatile stocks in KR Market | 2.5% |
Stable Share Price: A110020's share price has been volatile over the past 3 months compared to the KR market.
Volatility Over Time: A110020's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | n/a | Taehun Lee | www.jjbio.co.kr |
Jeonjinbio Co., Ltd. develops and produces natural bio-pesticides, alternative chemical products, and other biotechnology products. The company offers repellent for bird, boar, rodent, snake, and sea lice; and dress perfume, including Paris 16e, Paris 16e Bouquet, Bouquet Garni, and Bridcan, as well as mosquito repellent. It also provides laundry products.
Jeonjinbio Co., Ltd. Fundamentals Summary
| A110020 fundamental statistics | |
|---|---|
| Market cap | ₩26.13b |
| Earnings (TTM) | ₩956.41m |
| Revenue (TTM) | ₩15.45b |
Is A110020 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A110020 income statement (TTM) | |
|---|---|
| Revenue | ₩15.45b |
| Cost of Revenue | ₩10.98b |
| Gross Profit | ₩4.47b |
| Other Expenses | ₩3.51b |
| Earnings | ₩956.41m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 105.58 |
| Gross Margin | 28.91% |
| Net Profit Margin | 6.19% |
| Debt/Equity Ratio | 0% |
How did A110020 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/18 03:07 |
| End of Day Share Price | 2025/11/18 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Jeonjinbio Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.